Old Web
English
Sign In
Acemap
>
Paper
>
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection.
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection.
2020
Louise Cunningham
Ian Kimber
David A. Basketter
John McFadden
Keywords:
Interleukin 6
Coronavirus disease 2019
Perforin
Immunology
Macrophage activation syndrome
Anti-IL-6
Cytokine storm
2019 20 coronavirus outbreak
Diabetes mellitus
Medicine
Betacoronavirus
Pandemic
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
13
Citations
NaN
KQI
[]